Epigenetic silencing of microRNA-335 contributes to nasopharyngeal carcinoma metastasis
American Journal of Otolaryngology - Head and Neck Medicine and Surgery Oct 15, 2019
Yang JH, et al. - In this investigation involving 30 patients, researchers identified the impact of mircoRNA-335 (miR-335) methylation on metastasis of nasopharyngeal carcinoma. They applied RT-PCR and methylation-specific PCR to identify the expression levels of miR-335 and miR-335 methylation in nasopharyngeal carcinoma tissues. Compared with those with promoter unmethylation, the levels of miR-335 expression were significantly lower in nasopharyngeal cancer tissues with promoter methylation. In 14 out of 30 nasopharyngeal cancer tissues, the levels of miR-335 gene promoter methylation were higher. Moreover, compared with patients without cervical lymph node metastasis those with cervical lymph node metastasis had higher methylation rate in miR-335 promoter. Findings suggested an association of miR-335 methylation expression with nasopharyngeal carcinoma metastasis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries